U.S. Blood Plasma Collection Market

U.S. Blood Plasma Collection Market – U.S. Blood Plasma Collection Market Dynamics & Opportunities

Posté 2025-10-01 08:48:10

Executive Summary

The U.S. Blood Plasma Collection Market was valued at USD 5.50 billion in 2024 and is projected to reach USD 8.97 billion by 2032, growing at a CAGR of 6.3% during the forecast period from 2025 to 2032. This market encompasses the collection of blood plasma for therapeutic and diagnostic purposes, driven by increasing demand for plasma-derived therapies and advancements in collection technologies.

Market Overview

The U.S. blood plasma collection market is experiencing significant growth due to the rising prevalence of chronic diseases, advancements in plasma fractionation technologies, and the increasing demand for plasma-derived therapies such as immunoglobulins, clotting factors, and albumin. The market is characterized by a robust network of collection centers, regulatory frameworks ensuring donor safety, and continuous innovations in collection methods.

Market Size & Forecast

The market size was valued at USD 5.50 billion in 2024 and is projected to reach USD 8.97 billion by 2032, with a CAGR of 6.3% during the forecast period of 2025 to 2032. This growth is attributed to factors such as:

Increased Demand for Plasma-Derived Therapies: The rising prevalence of conditions like hemophilia, immune deficiencies, and neurological disorders is driving the demand for plasma-derived therapies.
Advancements in Collection Technologies: Innovations in automated plasma collection systems are enhancing efficiency and donor comfort.
Expansion of Collection Infrastructure: The establishment of new collection centers and expansion of existing facilities are increasing plasma collection capacity.

Market Segmentation

By Collection Method

Automated Plasma Collection: Dominated the market with a 68.9% share in 2024, offering improved efficiency and higher plasma yield.
Manual Plasma Collection: A traditional method with a smaller market share, primarily used in specific settings.

By Application

Hematological Analysis: Held the largest share in 2024, driven by routine diagnostics and blood disorder screening.
Molecular Biology: Expected to register the fastest CAGR of 8.5% from 2025 to 2032, due to increased genetic testing and infectious disease diagnostics.
Blood Glucose Analysis: A significant application area, particularly in diabetes management.
Sample Recovery: Important for various diagnostic and research purposes.

By End-User

Blood Banks: Held the highest share of 42.3% in 2024, central to large-scale plasma collection and distribution.
Pathology Labs and Diagnostic Centers: Expected to witness the fastest growth due to expansion in in-house collection and diagnostic services.
Hospitals: Utilize collected plasma for various therapeutic purposes.
Others: Includes research institutions and pharmaceutical companies.

Regional Insights

The U.S. leads the global blood plasma collection market, accounting for a significant share of the world's plasma supply. Factors contributing to this dominance include:

Regulatory Environment: The U.S. has established comprehensive regulatory frameworks ensuring donor safety and plasma quality.
Infrastructure: A vast network of collection centers and advanced processing facilities.
Market Demand: High demand for plasma-derived therapies both domestically and internationally.

Competitive Landscape

Key players in the U.S. blood plasma collection market include:

Grifols: A global healthcare company with a strong presence in plasma collection and fractionation.
CSL Plasma: Operates one of the largest networks of human blood plasma collection centers worldwide.
Terumo BCT: Develops and manufactures blood component collection technologies.
STRECK: Provides specialized blood collection products for laboratory applications.
SIO2 Material Science: Innovates in the development of advanced blood collection containers.

Trends & Opportunities

Technological Advancements: Integration of automation and digital technologies in plasma collection processes.
Sustainability Initiatives: Adoption of eco-friendly practices in collection and processing operations.
Global Expansion: U.S. companies expanding their plasma collection networks internationally to meet global demand.

Challenges & Barriers

Donor Recruitment: Challenges in maintaining a steady supply of voluntary donors.
Regulatory Compliance: Navigating complex regulatory requirements across different regions.
Operational Costs: High costs associated with setting up and maintaining collection centers and processing facilities.

Conclusion

The U.S. Blood Plasma Collection Market is poised for continued growth, driven by increasing demand for plasma-derived therapies, advancements in collection technologies, and expansion of collection infrastructure. Companies operating in this market must focus on innovation, regulatory compliance, and donor engagement to capitalize on emerging opportunities.